Christopher Winslow to Aged, 80 and over
This is a "connection" page, showing publications Christopher Winslow has written about Aged, 80 and over.
Connection Strength
0.053
-
Causes, Diagnostic Testing, and Treatments Related to Clinical Deterioration Events Among High-Risk Ward Patients. Crit Care Explor. 2024 Oct 01; 6(10):e1161.
Score: 0.027
-
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clin Cancer Res. 2014 Jan 15; 20(2):490-8.
Score: 0.026